Mosanna to Participate in BIO-EUROPE 2022 Partnering Forum

BASEL, October 19, 2022 – Mosanna Therapeutics, a preclinical-stage Biotech company focused on developing MOS-118, a pharmacologic therapy to treat obstructive sleep apnea (OSA), today announced that the CEO will participate in the Partnering Forum at the BIO-EUROPE 2022 Conference taking place in Liepzig, Germany, October 24-26, and virtually between Nov 2-4, 2022. Meeting schedules will be accessible to registered conference attendees.

To schedule a meeting, please do so via the partneringONE platform.